Neuroblastoma: a disease requiring a multitude of imaging studies
BH Kushner - Journal of Nuclear Medicine, 2004 - Soc Nuclear Med
Neuroblastoma stands out among pediatric solid tumors because of its relative frequency,
intriguing natural history, prognostic biologic features, and therapeutic challenges. It is the …
intriguing natural history, prognostic biologic features, and therapeutic challenges. It is the …
Current status and future perspective on molecular imaging and treatment of neuroblastoma
L Feng, S Li, C Wang, J Yang - Seminars in Nuclear Medicine, 2023 - Elsevier
Neuroblastoma is the most common extracranial solid tumor in children and arises from
anywhere along the sympathetic nervous system. It is a highly heterogeneous disease with …
anywhere along the sympathetic nervous system. It is a highly heterogeneous disease with …
MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies
A Agrawal, V Rangarajan, S Shah… - The British journal of …, 2018 - birpublications.org
Metaiodobenzylguanidine, a guanithidine analog, labeled with 123I and 131I, is used for
imaging and therapy of neuroblastomas and various neural crest tumors like …
imaging and therapy of neuroblastomas and various neural crest tumors like …
Pediatrics: diagnosis of neuroblastoma
SE Sharp, MJ Gelfand, BL Shulkin - Seminars in nuclear medicine, 2011 - Elsevier
Neuroblastoma is the most common pediatric extracranial soft-tissue tumor, accounting for
approximately 8% of childhood malignancies. Its prognosis is widely variable, ranging from …
approximately 8% of childhood malignancies. Its prognosis is widely variable, ranging from …
Integrated Imaging Using MRI and 123| Metaiodobenzylguanidine Scintigraphy to Improve Sensitivity and Specificity in the Diagnosis of Pediatric Neuroblastoma
T Pfluger, C Schmied, U Porn… - American Journal of …, 2003 - Am Roentgen Ray Soc
OBJECTIVE. The objectives of this study were to compare MRI and iodine-123 (123I)
metaiodobenzylguanidine (MIBG) scintigraphy in the detection of neuroblastoma lesions in …
metaiodobenzylguanidine (MIBG) scintigraphy in the detection of neuroblastoma lesions in …
Neuroblastoma and other neuroendocrine tumors
R Howman-Giles, PJ Shaw, RF Uren… - Seminars in nuclear …, 2007 - Elsevier
Neuroblastoma is the most common extracranial solid tumor of childhood. It commonly
presents in children younger than 2 years of age, with 90% being younger than 5 years of …
presents in children younger than 2 years of age, with 90% being younger than 5 years of …
Nuclear medicine and multimodality imaging of pediatric neuroblastoma
WP Mueller, E Coppenrath, T Pfluger - Pediatric Radiology, 2013 - Springer
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system and is
metastatic or high risk for relapse in nearly 50% of cases. Therefore, exact staging with …
metastatic or high risk for relapse in nearly 50% of cases. Therefore, exact staging with …
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR
E Lopci, A Piccardo, C Nanni, V Altrinetti… - Clinical nuclear …, 2012 - journals.lww.com
Aim: Role of 18 F-DOPA PET/CT in neuroblastoma (NB) compared with CT/MR. Materials
and Methods: In all, 21 patients (M: F= 14: 7; mean age, 7.4 years) affected by advanced …
and Methods: In all, 21 patients (M: F= 14: 7; mean age, 7.4 years) affected by advanced …
Neuroblastoma: MIBG imaging and new tracers
T Pfluger, A Piccardo - Seminars in Nuclear Medicine, 2017 - Elsevier
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system, and is
metastatic or otherwise high risk for relapse in nearly 50% of cases, with a long-term survival …
metastatic or otherwise high risk for relapse in nearly 50% of cases, with a long-term survival …
Detection and treatment of minimal residual disease in high‐risk neuroblastoma
CP Reynolds - Pediatric transplantation, 2004 - Wiley Online Library
Intensive, myeloablative therapy supported by autologous hematopoietic stem‐cell
transplantation (AHSCT) has improved the outcome for children with high‐risk …
transplantation (AHSCT) has improved the outcome for children with high‐risk …